153 related articles for article (PubMed ID: 38534997)
1. Comparison of Transoral and Transcervical Ultrasonography with MRI for the Diagnostic Work-Up of Oropharynx Tumors: A Protocol for a Multicenter Clinical Trial (SPOTUS).
Garset-Zamani M; Hvilsom GB; Kjærgaard T; Plaschke CC; Hahn CH; Kaltoft M; O'Leary P; Frid NL; Norling R; Dejanovic D; Hall JM; Agander TK; Nielsen SB; Ersbøll AK; Wessel I; Buchwald CV; Todsen T
Diagnostics (Basel); 2024 Mar; 14(6):. PubMed ID: 38534997
[TBL] [Abstract][Full Text] [Related]
2. Transoral Ultrasound in the Outpatient Clinic for the Diagnostic Work-Up of Oropharyngeal Cancer: A Feasibility Study.
Garset-Zamani M; Norling R; Hahn CH; Agander TK; von Buchwald C; Todsen T
Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958465
[TBL] [Abstract][Full Text] [Related]
3. Evaluating oropharyngeal carcinoma with transcervical ultrasound, CT, and MRI.
Faraji F; Coquia SF; Wenderoth MB; Padilla ES; Blitz D; DeJong MR; Aygun N; Hamper UM; Fakhry C
Oral Oncol; 2018 Mar; 78():177-185. PubMed ID: 29496048
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of ultrasound, ¹⁸F-FDG-PET/CT, and fused ¹⁸F-FDG-PET-MR images with DWI for the detection of cervical lymph node metastases of HNSCC.
Heusch P; Sproll C; Buchbender C; Rieser E; Terjung J; Antke C; Boeck I; Macht S; Scherer A; Antoch G; Heusner TA; Handschel J
Clin Oral Investig; 2014 Apr; 18(3):969-78. PubMed ID: 23892450
[TBL] [Abstract][Full Text] [Related]
5. Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease.
Pellini R; Manciocco V; Turri-Zanoni M; Vidiri A; Sanguineti G; Marucci L; Sciuto R; Covello R; Sperduti I; Kayal R; Anelli V; Pichi B; Mercante G; Spriano G
J Craniomaxillofac Surg; 2014 Dec; 42(8):1834-9. PubMed ID: 25150165
[TBL] [Abstract][Full Text] [Related]
6. Transcervical sonography and human papillomavirus 16 E6 antibodies are sensitive for the detection of oropharyngeal cancer.
Lang Kuhs KA; Wood CB; Wiggleton J; Aulino JM; Latimer B; Smith DK; Bender N; Rohde S; Mannion K; Kim Y; Sinard R; Langerman A; Fleischer A; Fakhry C; Waterboer T; Netterville JL
Cancer; 2020 Jun; 126(11):2658-2665. PubMed ID: 32129894
[TBL] [Abstract][Full Text] [Related]
7. Visualization of the Oropharynx With Transcervical Ultrasound.
Coquia SF; Hamper UM; Holman ME; DeJong MR; Subramaniam RM; Aygun N; Fakhry C
AJR Am J Roentgenol; 2015 Dec; 205(6):1288-94. PubMed ID: 26587936
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
9. PET/MR versus PET/CT for locoregional staging of oropharyngeal squamous cell cancer.
Flygare L; Erdogan ST; Söderkvist K
Acta Radiol; 2023 May; 64(5):1865-1872. PubMed ID: 36464816
[TBL] [Abstract][Full Text] [Related]
10. The use of ultrasound in the search for the primary site of unknown primary head and neck squamous cell cancers.
Fakhry C; Agrawal N; Califano J; Messing B; Liu J; Saunders J; Ha P; Coquia S; Hamper U; Gillison M; Blanco R
Oral Oncol; 2014 Jul; 50(7):640-5. PubMed ID: 24819862
[TBL] [Abstract][Full Text] [Related]
11. Prospective Comparison of 18F-Choline Positron Emission Tomography/Computed Tomography (PET/CT) and 18F-Fluorodeoxyglucose (FDG) PET/CT in the Initial Workup of Multiple Myeloma: Study Protocol of a Prospective Imaging Trial.
Mesguich C; Hulin C; Latrabe V; Asselineau J; Bordenave L; Perez P; Hindie E; Marit G
JMIR Res Protoc; 2020 Sep; 9(9):e17850. PubMed ID: 32909953
[TBL] [Abstract][Full Text] [Related]
12. Clinical Value of Fused PET/MRI for Surgical Planning in Patients With Oral/Oropharyngeal Carcinoma.
Hayashi K; Kikuchi M; Imai Y; Yamashita D; Hino M; Ito K; Shimizu K; Harada H; Shinohara S
Laryngoscope; 2020 Feb; 130(2):367-374. PubMed ID: 30897225
[TBL] [Abstract][Full Text] [Related]
13. Is there an additive value of 18 F-FDG PET-CT to CT/MRI for detecting nodal metastasis in oropharyngeal squamous cell carcinoma patients with palpably negative neck?
Sohn B; Koh YW; Kang WJ; Lee JH; Shin NY; Kim J
Acta Radiol; 2016 Nov; 57(11):1352-1359. PubMed ID: 26013025
[TBL] [Abstract][Full Text] [Related]
14. Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx.
Kim MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Eur J Surg Oncol; 2007 Jun; 33(5):633-8. PubMed ID: 17391904
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of 18F-FDG PET/CT in low 18F-FDG-avidity breast cancer subtypes: comparison with breast US and MRI.
Park HL; Yoo IR; O JH; Kim H; Kim SH; Kang BJ
Nucl Med Commun; 2018 Jan; 39(1):35-43. PubMed ID: 28984814
[TBL] [Abstract][Full Text] [Related]
16. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
[TBL] [Abstract][Full Text] [Related]
17. Management of head and neck primary unknown squamous cell carcinoma using combined positron emission tomography-computed tomography and transoral laser microsurgery.
Kuta V; Williams B; Rigby M; Hart R; Trites J; MacKay C; Taylor SM
Laryngoscope; 2018 Oct; 128(10):2307-2311. PubMed ID: 29214640
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
19. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
Odalovic S; Stojiljkovic M; Sobic-Saranovic D; Pandurevic S; Brajkovic L; Milosevic I; Grozdic-Milojevic I; Artiko V
Neoplasma; 2017; 64(6):954-961. PubMed ID: 28895416
[TBL] [Abstract][Full Text] [Related]
20. FDG PET/CT for metastatic squamous cell carcinoma of unknown primary of the head and neck.
Liu Y
Oral Oncol; 2019 May; 92():46-51. PubMed ID: 31010622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
